2023 Annual Meeting | C86 - Dopaminergic Therapy for Motor Symptoms in Early Parkinson's Disease

Date Monday 04/24/23

Time 11:15 AM - 12:15 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Tamara M. Pringsheim, MD, FAAN

Topic(s) Movement Disorders

Learning Objectives Participants will become familar with the AAN Practice Parameter: Initiation of Dopaminergic Therapy for Motor Symptoms in Early PD; when to initiate pharmacological therapy for motor symptoms in early Parkinson's disease; with what to initiate therapy for motor symptoms in early Parkinson's disease; and how to monitor dopaminergic therapy for motor symptoms in early Parkinson's disease.

This program is supported in part by an educational grant from Cerevel Therapeutics

The Academy was solely responsible, with no influence from the industry supporter, for selection of content, format, presenters, and moderators of this CME program, and the speakers have not been contacted or influenced in any way by the industry supporter with regard to this CME program.

CME Available 1.00 CME credit

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Audience Participation

Event Timeline
11:15 AM - 11:25 AM EST	Introduction	Dopaminergic Therapy for Motor Symptoms in Early Parkinson's disease Tamara M. Pringsheim, MD, FAAN
11:25 AM - 11:40 AM EST	Speaker	Case 1 Robertus M. De Bie, MD
11:40 AM - 11:55 AM EST	Speaker	Case 2 Robertus M. De Bie, MD
11:55 AM - 12:10 PM EST	Speaker	Case 3 Tamara M. Pringsheim, MD, FAAN
12:10 PM - 12:15 PM EST	Closing Remarks	Summary Recommendations Tamara M. Pringsheim, MD, FAAN

Faculty Disclosures
Tamara M. Pringsheim, MD, FAAN	The institution of Dr. Pringsheim has received research support from Canadian Institutes of Health Research. The institution of Dr. Pringsheim has received research support from Azrieli Accelerator.
Robertus M. De Bie, MD	No disclosure on file